Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 29939 matches for

The collaboration has led to the first pre-clinical model of acute erythroid leukaemia.

Acute erythroid leukemia commonly involves both myeloid and erythroid lineage transformation. Di Genua et al. show that combined Cebpa and Gata2 mutations induce bi-lineage AEL. The Gata2 mutation (bottom soil layer) increases chromatin accessibility of erythroid transcription factor motifs (red roots) and decreases chromatin accessibility of myeloid transcription factor motifs (blue roots) while bi-allelic Cebpa mutation (top soil layer) increases erythroid transcription factor expression. This transforms neutrophil-monocyte progenitors into bi-potent leukemia-initiating cells that produce both myeloid and erythroid blasts (red and blue flowers, respectively). Artwork by Rae Cook.
Acute erythroid leukemia commonly involves both myeloid and erythroid lineage transformation. Di Genua et al. show that combined Cebpa and Gata2 mutations induce bi-lineage AEL. The Gata2 mutation (bottom soil layer) increases chromatin accessibility of erythroid transcription factor motifs (red roots) and decreases chromatin accessibility of myeloid transcription factor motifs (blue roots) while bi-allelic Cebpa mutation (top soil layer) increases erythroid transcription factor expression. This transforms neutrophil-monocyte progenitors into bi-potent leukemia-initiating cells that produce both myeloid and erythroid blasts (red and blue flowers, respectively). Artwork by Rae Cook.

Information for NDCLS staff and students

About NDCLS

Nuffield Division of Clinical Laboratory Sciences

About OCDEM

OCDEM is one of the leading research centres in diabetes, endocrinology and metabolism in the UK.

Advanced Imaging Suite

Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM)

Patient and Public Involvement and Engagement in CV Med

In this section you will find out about how we support patient and public involvement and engagement in our research, and how to get involved in our current studies.

Research Nurse and Support Team

This team of highly skilled and experienced research professionals support a diverse portfolio of research across the Division, and provide study participants with the highest standard of care and professionalism.

Division of Cardiovascular Medicine

About CV Med

Research in IMD

About IMD

The Investigative Medicine Division houses the Translational Immune Discovery Unit (TIDU).

Investigative Medicine Division

Meet the team

Spinout companies

RDM Principal Investigators have been the founders, or co-founders, of 18 spinout companies since 2010. This is one of the main ways in which we turn research discoveries into innovations that generate impact, and ultimately clinical benefit for patients.

Confirmation of Status Application

Appointment of Examiners Application & Thesis Submission

Milestone Applications

Transfer of Status Application

Email signatures

Load More

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories